01 June | 18:30 - 19:45 CEST 
Boehringer Ingelheim - Challenges in the management of systemic sclerosis-associated interstitial lung disease (SSc-ILD)
Speaker (s): Various 

01 June | 18:30 - 19:45 CEST 
AbbVie - JAK Inhibitors in Rheumatic Conditions and their Role in Helping Patients Reach Treatment Goals
Speaker (s): Various

01 June | 18:30 - 19:45 CEST
UCB - Raising the Target for Patients Living with Axial Spondyloarthritis
Speaker (s): Various

01 June | 18:30 - 19:45 CEST
Pfizer - The Enduring Value of TNF Inhibitors: Lessons Learnt and Opportunities for Further Optimisation
Speaker (s): Various

01 June | 18:30 - 19:45 CEST
AstraZeneca - Rewriting lupus: turning the page on the management of SLE
Speaker (s): Various

01 June | 18:30 - 19:45 CEST
Bristol-Myers Squibb - Concept to Practice: Deliberating “At Risk” RA
Speaker (s): Various

02 June | 08:15 - 09:30 CEST
Pfizer - There is a Cardiologist in the Rheum!
Speaker (s): Various

02 June | 08:15 - 09:30 CEST
Novartis - Making the invisible visible in PsA and axSpA
Speaker (s): Various

02 June | 08:15 - 09:30 CEST
Amgen - Slipping through the cracks: Overcoming the challenges in managing patients with moderate PsA
Speaker (s): Various

02 June | 08:15 - 09:30 CEST
Medac - Methotrexate in current clinical practice: optimizing the anchor drug in RA therapy
Speaker (s): Various

02 June | 08:15 - 09:30 CEST
Celltrion Healthcare - Rerouting IFX Therapy from IV to SC: Can It Open New Doors?
Speaker (s): Various

02 June | 08:15 - 09:30 CEST
Fresenius Kabi - Sailing towards the same destination: How do we manage the treatment strategy in RA patients?
Speaker (s): Various

02 June | 17:30 - 18:45 CEST
AstraZeneca - Elevating Treatment Expectations in SLE
Speaker (s): Various

02 June | 17:30 - 18:45 CEST
Bristol Myers Squibb - Hidden in Plain Sight: TYK2 as an Emerging Pathway in Lupus and Psoriatic Arthritis
Speaker (s): Various

02 June | 17:30 - 18:45 CEST
Janssen - Above the stratosphere: a new frontier in PsA management
Speaker (s): Various

02 June | 17:30 - 18:45 CEST
Galapagos - Evolving patient care: can JAK inhibitors meet patient and physician expectations for RA treatment?
Speaker (s): Various

02 June | 17:30 - 18:45 CEST
GSK - Looking to the Future of RA Management
Speaker (s): Various

02 June | 17:30 - 18:45 CEST
Lilly - 5-YEAR’S and BEYOND with Baricitinib
Speaker (s): Various

03 June | 08:15 - 09:30 CEST
Vifor - An alternative treatment pathway in ANCA-associated vasculitis
Speaker (s): Various

03 June | 08:15 - 09:30 CEST
AbbVie - Boosting your knowledge of spondyloarthritis: How to navigate the shifting field of axial SpA
Speaker (s): Various

03 June | 08:15 - 09:30 CEST
UCB - Raising the Target for Patients Living with Psoriatic Arthritis
Speaker (s): Various

03 June | 08:15 - 09:30 CEST
GlaxoSmithKline - Thinking short - and long-term in SLE: is disease modification possible?
Speaker (s): Various

03 June | 08:15 - 09:30 CEST
Pfizer - Finding the Balance: Efficacious Treatment of AS While Managing Safety and Risk
Speaker (s): Various

03 June | 08:15 - 09:30 CEST
Lilly - Spondyloarthritis: treating the patient, not the disease
Speaker (s): Various

03 June | 17:30 - 18:45 CEST
Janssen - 2022, an ImmunOdyssey: IL-23 pathway in immune-mediated diseases
Speaker (s): Various

03 June | 17:30 - 18:45 CEST
AbbVie - JAK of All Trades - A new standard of care in RA and PsA?
Speaker (s): Various

03 June | 17:30 - 18:45 CEST
GlaxoSmithKline - Bridging the gap: building effective patient–clinician communications in systemic lupus erythematosus (SLE)
Speaker (s): Various

03 June | 17:30 - 18:45 CEST
UCB - Evolving Concepts in axSpA – 2022 Update
Speaker (s): Various

03 June | 17:30 - 18:45 CEST
Lilly - JAK Inhibitors: Translating Data to Clinical Practice
Speaker (s): Various

03 June | 17:30 - 18:45 CEST
GlaxoSmithKline - Understanding EGPA: A new era for patient management
Speaker (s): Various

01 June | 15:45 - 16:15 CEST
GlaxoSmithKline - Thinking short- and long-term in SLE: is disease modification possible?
Speaker(s): Prof. Dr. Ronald van Vollenhoven, Dr. Johanna Mucke, Prof. Luca Iaccarino

01 June | 15:45 - 16:15 CEST
Galapagos - Patient-centred care in RA: cutting through the jargon
Speaker(s): MD, PhD Lars Erik Kristensen

02 June | 09:45 - 10:15 CEST
Novartis - AOSD: improving patients’ treatment with targeted strategies
Speaker(s): Prof. Lorenzo Dagna, PD Dr. Jürgen Rech

02 June | 09:45 - 10:15 CEST
Janssen - Intervene and intercept: can we prevent PsA early in disease development?
Speaker(s): MD, PhD Lars Erik Kristensen, Prof. Lars Iversen

02 June | 09:45 - 10:15 CEST
Boehringer Ingelheim - Protecting the lungs in patients with autoimmune diseases
Speaker(s): Prof. Dr. Michael Kreuter

02 June | 15:00 - 15:30 CEST
UCB - Enthesitis Management
Speaker(s): Prof. Rik Lories, Dr. Philippe Carron

02 June | 15:00 - 15:30 CEST
Pfizer - How to Channel Your Inner Cardiologist!
Speaker(s): Prof. Fabiola Atzeni, MD, PhD Anne Grete Semb

03 June | 09:45 - 10:15 CEST
Pfizer - An Experience- and Evidence-Based Approach for the Treatment of PsA
Speaker(s): Prof. Laura Coates, Dr. med. Frank Behrens

03 June | 09:45 - 10:15 CEST
Janssen - Journey to the centre: axial involvement of PsA
Speaker(s): Prof. Dr. Mikkel Østergaard, Prof. Dr. Denis Poddubnyy

03 June | 09:45 - 10:15 CEST
Vifor - ANCA vasculitis – what should you be concerned about? Assessing the impact of treatment choices
Speaker(s): Prof. Dr. Bernhard Hellmich